Maite Bourlon: Great systematic review and Network Meta-Analysis for 1st line combinarions in metastatic urothelial carcinoma
Maria T Bourlon shared a post by Fernando Sabino M Monteiro, Medical Oncologist at Hospital Sírio-Libanês, Brazil on X/Twitter, adding:
“Great systematic review and Network Meta-Analysis for 1st line combinarions in metastatic urothelial carcinoma.”
Quoting Fernando Sabino M Monteiro’s post:
“Just out at Critical Reviews in Oncology Hematology (CROH) the 1st systematic review and NMA with immune-combos in 1st line mUC (including the data of EV-302 just published).”
Source: Maite Bourlon/X and Fernando Sabino M Monteiro/X
Maria T Bourlon is an Associate Professor and Head of the Urologic Oncology Clinic at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico. She is the Director of the Genitourinary Cancers Program at Universidad Nacional Autónoma de México. Dr. Bourlon is the chair-elect of the American Society of Clinical Oncology IDEA Steering Group and in 2023 received the prestigious ASCO CCF International Women Who Conquer Cancer (WWCC) Mentorship Award. She is on the Editorial Board of OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023